Pyxis Oncology, Inc. (PYXS)
NASDAQ · Healthcare
Pyxis Oncology, Inc. Shareholder Equity 2024–2025
Pyxis Oncology, Inc. annual shareholder equity history from 2024 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Pyxis Oncology, Inc. shareholder equity as of December 31, 2025: 53.4M, a 55.77% decrease year-over-year.
- Pyxis Oncology, Inc. shareholder equity for 2025 were 53.4M, a 55.77% decrease from 2024.
- Pyxis Oncology, Inc. shareholder equity for 2024 were 120.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Pyxis Oncology, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $53 |
| 2024 | $121 |
Pyxis Oncology, Inc. Shareholder Equity — FAQ
Pyxis Oncology, Inc. (PYXS) shareholder equity over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PYXS's shareholder equity history?
The chart and table above show Pyxis Oncology, Inc.'s shareholder equity by year and by quarter, including the growth rate.